Cargando…
High GPER expression in triple-negative breast cancer is linked to pro-metastatic pathways and predicts poor patient outcomes
Triple-negative breast cancer (TNBC) is a particularly aggressive and heterogeneous disease with few effective targeted therapies and precision therapeutic options over a long period. It is generally considered that TNBC is an estrogen-independent breast cancer, while a new estrogen receptor, namely...
Autores principales: | Xu, Ting, Ma, Ding, Chen, Sheng, Tang, Rui, Yang, Jianling, Meng, Chunhui, Feng, Yang, Liu, Li, Wang, Jiangfen, Luo, Haojun, Yu, Keda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9427744/ https://www.ncbi.nlm.nih.gov/pubmed/36042244 http://dx.doi.org/10.1038/s41523-022-00472-4 |
Ejemplares similares
-
Oestrogen Inhibits VEGF Expression And Angiogenesis In Triple-Negative Breast Cancer By Activating GPER-1
por: Wang, Chen, et al.
Publicado: (2018) -
Prognostic role of GPER/Ezrin in triple-negative breast cancer is associated with menopausal status
por: Ye, Shuang, et al.
Publicado: (2019) -
The G Protein-Coupled Estrogen Receptor (GPER) Expression Correlates with Pro-Metastatic Pathways in ER-Negative Breast Cancer: A Bioinformatics Analysis
por: Talia, Marianna, et al.
Publicado: (2020) -
Female Heart Health: Is GPER the Missing Link?
por: Groban, Leanne, et al.
Publicado: (2020) -
Focal adhesion kinase (FAK) activation by estrogens involves GPER in triple-negative breast cancer cells
por: Rigiracciolo, Damiano Cosimo, et al.
Publicado: (2019)